Explaining variability in early stages of [18F]‐flortaucipir tau‐PET binding: Focus on sex differences

Documenti analoghi

• Hypertension and cerebral blood flow in the development of Alzheimer's disease
  di: Dario Bachmann, et al.
  Pubblicazione: (2024)
• Predicting cognitive decline with amyloid‐PET, plasma p‐tau217, Aβ42/40, and p‐tau217/Aβ42 in a community‐based cohort – relevance for clinical trial enrollment
  di: Dario Bachmann, et al.
  Pubblicazione: (2025)
• Survey among experts on the future role of tau‐PET in clinical practice and trials
  di: Marie R. Vermeiren, et al.
  Pubblicazione: (2024)
• Elevated tau in the piriform cortex in Alzheimer's but not Parkinson's disease using PET‐MR
  di: Hossein Moein Taghavi, et al.
  Pubblicazione: (2024)
• Resistance and resilience to tau pathology in Alzheimer's disease: Effects of age, sex, and APOE alleles
  di: Yury Loika, et al.
  Pubblicazione: (2024)